$The economic impact of enoxaparin versus unfractionated heparin for prevention of venous thromboembolism in acute ischemic stroke patients$

The economic impact of enoxaparin versus unfractionated heparin for prevention of venous thromboembolism in acute ischemic stroke patients

Graham F Pineo1, Jay Lin2, Lieven Annemans31Department of Medicine, University of Calgary, Calgary, Alberta, Canada; 2Novosys Health, Flemington, NJ; 3Department of Medicine, Ghent University, Ghent and Brussels University, Brussels, BelgiumAbstract: Venous thromboembolism (VTE) is a common complica...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Pineo GF, Lin J, Annemans L
Формат:	Өгүүллэг
Хэл сонгох:	English
Хэвлэсэн:	Dove Medical Press 2012-04-01
Цуврал:	ClinicoEconomics and Outcomes Research
Онлайн хандалт:	http://www.dovepress.com/the-economic-impact-of-enoxaparin-versus-unfractionated-heparin-for-pr-a9748

Ижил төстэй зүйлс

Venous Thromboembolism Prophylaxis with Enoxaparin Versus Unfractionated Heparin in Patients with Low Body Weight
-н: David Michael Kaylor PharmD, зэрэг
Хэвлэсэн: (2023-02-01)

Differential Neutralization of Unfractionated Heparin and Enoxaparin by Andexanet Alfa
-н: Joseph Lewis BA, зэрэг
Хэвлэсэн: (2022-05-01)

Outcomes of thromboprophylaxis with enoxaparin vs. unfractionated heparin in medical inpatients
-н: Thompson David, зэрэг
Хэвлэсэн: (2006-09-01)

Effectiveness, safety, and costs of thromboprophylaxis with enoxaparin or unfractionated heparin in inpatients with obesity
-н: Alpesh Amin, зэрэг
Хэвлэсэн: (2023-06-01)

PHARMACO-ECONOMIC COMPARISON OF ENOXAPARIN AND UNFRACTIONATED HEPARIN IN ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION
-н: A. V. Syrov, зэрэг
Хэвлэсэн: (2010-04-01)

Cost-utility of enoxaparin compared with unfractionated heparin in unstable coronary artery disease
-н: Milne Ruairidh, зэрэг
Хэвлэсэн: (2001-10-01)

Assay-Based Differentiation in the Neutralization Profile of Unfractionated Heparin, Enoxaparin, and Fondaparinux by Andexanet Alfa
-н: Fakiha Siddiqui BDS, зэрэг
Хэвлэсэн: (2020-01-01)

Enoxaparin versus Unfractionated Heparin for the Perioperative Anticoagulant Therapy in Patients with Mechanical Prosthetic Heart Valve Undergoing Non-Cardiac Surgery
-н: Luminita Iliuta, зэрэг
Хэвлэсэн: (2022-08-01)

Comparison of the Effect of Unfractionated Heparin and Enoxaparin Sodium at Different Doses on the Course of COVID-19-Associated Coagulopathy
-н: Oleksandr Oliynyk, зэрэг
Хэвлэсэн: (2021-09-01)

Randomized, Blinded Trial Comparing Enoxaparin with Unfractionated Heparin in Patients Undergoing Contemporary Percutaneous Coronary Intervention
-н: Hosein Vakili, зэрэг
Хэвлэсэн: (2007-04-01)

Randomized, Blinded Trial Comparing Enoxaparin with Unfractionated Heparin in Patients Undergoing Contemporary Percutaneous Coronary Intervention
-н: Hosein Vakili, зэрэг
Хэвлэсэн: (2007-07-01)

Unfractionated Heparin with Sequential Enoxaparin in Patients with Complex Coronary Artery Lesions during Percutaneous Coronary Intervention
-н: Zhi-Zhong Li, зэрэг
Хэвлэсэн: (2018-01-01)

Heparin versus enoxaparine for prevention of asymptomatic deep venous thrombosis after total knee arthroplasty
-н: Adnan H. Hnoosh, зэрэг
Хэвлэсэн: (2013-01-01)

Evaluation of anti-Xa levels in patients with venous thromboembolism within the first 48 h of anticoagulation with unfractionated heparin
-н: Lily Nguyen, зэрэг
Хэвлэсэн: (2023-08-01)

Standard dosing of enoxaparin versus unfractionated heparin in critically ill patient with COVID-19: a multicenter propensity-score matched study
-н: Khalid Al Sulaiman, зэрэг
Хэвлэсэн: (2022-12-01)

Unfractionated Heparin in SARS-CoV-2 Pneumonia: Ischemic Stroke Case Report
-н: Aslan Efendizade, зэрэг
Хэвлэсэн: (2020-09-01)

Comparison of Intravenous Enoxaparin with Subcutaneous Enoxaparin in Preventing Venous Thromboembolism in Patients Admitted to Intensive Care Unit
-н: Masoum Khoshfetrat, зэрэг
Хэвлэсэн: (2020-05-01)

Safety and efficacy of low-molecular-weight heparin in patients with acute venous thromboembolism postthrombolytic therapy as compared to unfractionated heparin: A systematic review and meta-analysis
-н: Eman M. Mansory, зэрэг
Хэвлэсэн: (2024-12-01)

Prevention of venous thromboembolic events in ischemic stroke
-н: Vladimir Anatolyevich Parfenov
Хэвлэсэн: (2013-11-01)

Heparin versus Danaproid for Prevention of Venous Thromboembolism after Hip Surgery
-н: J Nakase, зэрэг
Хэвлэсэн: (2009-04-01)

The effect of unfractionated heparin, enoxaparin, and danaparoid on lupus anticoagulant testing: Can activated carbon eliminate false‐positive results?
-н: Pieter M.M. De Kesel, зэрэг
Хэвлэсэн: (2020-01-01)

Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study
-н: Javier Trujillo‐Santos, зэрэг
Хэвлэсэн: (2022-05-01)

Effectiveness, Safety, and Costs of Thromboprophylaxis with Enoxaparin or Unfractionated Heparin Among Medical Inpatients With Chronic Obstructive Pulmonary Disease or Heart Failure
-н: Alpesh N. Amin, зэрэг
Хэвлэсэн: (2024-02-01)

Intravenous thrombolysis in acute ischemic stroke after antagonization of unfractionated heparin with protamine: case series and systematic review of literature
-н: Katharina Kneer, зэрэг
Хэвлэсэн: (2023-01-01)

Dabigatran versus Enoxaparin in the prevention of venous thromboembolism after total knee arthroplasty: A randomized clinical trial
-н: Ahmad Mirdamadi, зэрэг
Хэвлэсэн: (2014-11-01)

Distinct effects of unfractionated heparin versus bivalirudin on circulating angiogenic peptides.
-н: Navin K Kapur, зэрэг
Хэвлэсэн: (2012-01-01)

Delayed prophylaxis with unfractionated heparin increases the risk of venous thromboembolic events in patients with moderate to severe traumatic brain injury: a retrospective analysis
-н: Giovanna Brandi, зэрэг
Хэвлэсэн: (2020-03-01)

Optimal Dosing of Enoxaparin in Critically Ill Patients with Venous Thromboembolism
-н: Aliya Abdulla, зэрэг
Хэвлэсэн: (2023-02-01)

Apixaban versus enoxaparin to prevent venous thromboembolism in post-operative patients with gynecologic cancers at an urban academic medical center
-н: Victoria Diamond, зэрэг
Хэвлэсэн: (2024-12-01)

Biosimilar versus branded enoxaparin to prevent postoperative venous thromboembolism after surgery for digestive tract cancer: Randomized trial
-н: Chadli Dziri, зэрэг
Хэвлэсэн: (2023-01-01)

Biosimilar versus branded enoxaparin to prevent postoperative venous thromboembolism after surgery for digestive tract cancer: Randomized trial.
-н: Chadli Dziri, зэрэг
Хэвлэсэн: (2023-01-01)

Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty
-н: Levitan B, зэрэг
Хэвлэсэн: (2014-03-01)

Bemiparin Versus Enoxaparin for Extended Thromboprophylaxis in COVID-19 Patients at High Risk of Venous Thromboembolism
-н: Ahmet Can TOPÇU, зэрэг
Хэвлэсэн: (2021-01-01)

Low-Dose Unfractionated Heparin with Sequential Enoxaparin in Patients with Diabetes Mellitus and Complex Coronary Artery Disease during Elective Percutaneous Coronary Intervention
-н: Ji Huang, зэрэг
Хэвлэсэн: (2018-01-01)

Unfractionated heparin in acute chest syndrome: a pilot feasibility randomized controlled trial of unfractionated heparin vs. standard of care in acute chest syndrome
-н: Craig D. Seaman, зэрэг
Хэвлэсэн: (2020-11-01)

Unfractionated heparin and mechanical thromboprophylaxis in hip arthroplasty
-н: Flávio Luís Garcia, зэрэг
Хэвлэсэн: (2015-08-01)

Higher Adherence to Treatment With Low-Molecular-Weight-Heparin Nadroparin Than Enoxaparin Because of Side Effects in Cancer-Associated Venous Thromboembolism
-н: Sake J. van der Wall, зэрэг
Хэвлэсэн: (2018-02-01)

COST- EFFECTIVENESS ANALYSIS OF APIXABANO VS. ENOXAPARIN IN THE THROMBOEMBOLISM IN THE PREVENTION OF VENOUS THROMBOEMBOLISM AFTER ARTHROPLASTY ELECTIVE THE HIP OR KNEE
-н: Óscar Lourenço, зэрэг
Хэвлэсэн: (2012-12-01)

The use of enoxaparin to prevent venous thromboembolism in patients undergoing radical retropubic prostatectomy: feasibility and utility
-н: Kogenta Nakamura, зэрэг
Хэвлэсэн: (2007-06-01)

Enoxaparin Dosing for Venous Thromboembolism Prophylaxis in Low Body Weight Patients
-н: Daniel Dybdahl, зэрэг
Хэвлэсэн: (2019-07-01)